The results of our current and previous studies show that CUL4A exhibits a positive correlation with poor prognosis of iCCA, probably through intact activated autophagy, and that targeting autophagy may be a potential therapeutic approach for iCCA treatment. The gene discussed is CUL4A; the disease is infantile convulsions and choreoathetosis.